Business intelligence
for the Lab Diagnostics industry
Already a Subscriber? Log in Here
We offer four monthly reports, each focused on the industry from a unique angle, covering science & technology, compliance, business, and legislation & regulations.
Diagnostic Testing & Emerging Technologies
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Lab Compliance Advisor
Offers practical, “what-to-do” and “how-to-do-it” help to comply with the latest state and federal laws, rules, and regulations that affect your diagnostic lab or pathology practice
Laboratory Industry Report
Keeps you up-to-date on lab business and competitive strategy, market trends and opportunities, and M&A and investment activity in today’s diagnostic lab industry
National Lab Reporter
Keeps you up-to-date on federal and state laws, regulations, new legislation, and court cases that affect your diagnostic lab or pathology practice
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
Current Diagnostics Merger & Acquisition Trends
M&A deals in the diagnostics industry have been lower in number, but higher in impact in recent months.
Clinical Lab Owner Pleads Guilty to Healthcare-Related Scheme
On Nov. 15, a psychiatrist and clinical lab owner pled guilty to his role in a complicated $3.8 million fraud scheme.
White House Proposes New AI “Bill of Rights”
US takes first steps to rein in abusive and privacy-invasive use of AI by corporations.
FDA to Consider Health Disparities in Granting Breakthrough Device Designation
Medical device makers will have to show that their products will be accessible to disadvantaged populations.
The State of State Licensing Law Restrictions on Telehealth
With temporary waivers of restriction relating to telehealth likely to end soon, here’s a roundup of the current state of state telehealth licensing law.
Four Things You Need to Know About the 2023 OPPS Payments Rule
The final Outpatient Prospective Payment System Final Rule for 2023 provides for a rate increase of nearly four percent.
Court Nixes COVID-19 Lab Test Reimbursement Lawsuit Against Private Payor
Despite Congress’ clear policy on private insurer payment of COVID-19 tests, many labs have been struggling to get reimbursed.
Five Things Labs Need to Know About the 2023 Clinical Lab and Physician Fee Schedule
In case you don’t feel like reading all 3,300+ pages of the Final Rule, here’s a quick briefing on the main changes you should be aware of.
Weekly Enforcement Report: COVID-19-Related Cases Take Center Stage
Though light on lab-related cases, last week’s enforcement actions cracked down on COVID-19-related violations.
CMS Hikes 2023 Medicare OPPS Reimbursement Rate 3.8 Percent
However, the increase still isn’t enough to keep pace with inflation, providers contend.
Healthcare Staffing Shortages Are Number 1 Issue in Recent Report
While likely not a surprise to medical labs, a new report may add more urgency to solving recruitment and retention issues.
Call for Speakers & Topics — G2 Intelligence Webinars & Events
We’re inviting our readers to share their ideas for topics and presenters, both for future standalone webinars and our virtual events.
CMS Publishes Final Clinical Laboratory Fee Schedule for 2023
The Final Rule caps future PAMA cuts at 15 percent per calendar year.
